Michelson awarded grant to develop mini optical probe
This article was originally published in Clinica
Executive Summary
The UK government’s Technology Strategy Board has awarded Michelson Diagnostics a £25,000 grant. The money will be used to fund a study into the feasibility of miniaturised optical coherence tomography (OCT) probes for cancer diagnosis. The probes are intended to be attached to the Orpington, UK-based firm’s VivoSight multi-beam OCT scanner, which it CE marked for sale in Europe in October. The scanner is designed to provide images of sub-surface tissue at a "far higher" resolution than other imaging modalities, allowing visualisation of the epidermis, dermis and sub-surface blood vessels. Michelson is hoping to advance the product further via development partnerships with firms such as suppliers of miniature components and commercial partners.